FINWIRES · TerminalLIVE
FINWIRES

$HXL

2 stories mentioning HXLUpdated 41d ago

Every FINWIRES story that references HXL, newest first.

Research

Research Alert: CFRA Maintains Hold Recommendation On Shares Of Hexcel Corporation

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our 12-month target price by $7 to $97, or 31.7x our 2027 EPS estimate, vs. HXL's three-year average forward P/E of 30.5x and peers' 36.5x. We raise our 2026 EPS estimate by $0.08 to $2.36 and 2027's by $0.10 to $3.06. Hexcel's Q1 results underscore a robust fundamental outlook, stemming from a strengthening commercial aerospace recovery. Commercial aerospace sales surged 18.8% Y/Y, fueled by rising build rates for key programs like the Airbus A350 and A320, and the Boeing 787 and 737 MAX, with A350 production expected at around 80 units in 2026. This volume growth is generating significant operating leverage, with gross margin expanding to 26.9% and adjusted operating income up 49%, as the company utilizes existing capacity. While Defense, Space & Other sales declined due to a prior divestiture, missile-related demand is expected to accelerate in 2H 2026. Hexcel is well positioned as a leading composites supplier, benefiting from increasing composite penetration in aircraft for fuel efficiency.

$HXL
Research

Research Alert: Hexcel Posts Q1 Beat On Top And Bottom Lines, Strong Margin Expansion

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:HXL posted Q1 adjusted EPS of $0.59 vs. $0.37 prior year, $0.15 above consensus, on sales of $501.5M (+9.9% Y/Y), beating consensus by $18M. Commercial Aerospace sales rose 18.8% Y/Y to $332.7M, led by A350, A320neo, 787, and 737 MAX programs as destocking pressures abated. The results validate our multiyear thesis on operating leverage, with 59.5% EPS growth on sub-10% sales growth as volumes recover into existing capacity. Management reaffirmed 2026 guidance for sales of $2.0B-$2.1B and adjusted EPS of $2.10-$2.30 despite geopolitical uncertainties. Adjusted operating margin expanded 360 bps Y/Y to 13.5%, demonstrating substantial fixed cost leverage. We believe HXL is well positioned to capture incremental revenue from sole-source contracts without material capacity additions, with line of sight to mid-30s incremental margins through 2027, though sustained progress remains contingent on OEM execution and supply chain stability.

$HXL

Track with the FINWIRES app suite